secondary outcome measures

(redirected from secondary end points)

secondary outcome measures

The outcome measures in a clinical trial that provide information on therapeutic effects of secondary importance, side effects or tolerability. Data on secondary outcomes are used to evaluate additional effects of the intervention not included in the primary outcome measure.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive ?
Secondary end points were all-cause death, and additional cardiovascular outcomes, including another stroke, heart attack, stroke progression, and symptomatic hypotension.
Numerous prespecified secondary end points also showed significantly greater improvement with quetiapine than placebo.
Cardiovascular deaths were secondary end points in both trials.
Secondary end points were predictors of AOM encounters at which no antibiotic prescribing was reported and the rates of antibiotic prescribing and analgesic prescribing.
Speaking at the annual meeting of the Heart Failure Society of America, he did not give more specific results on exercise capacity changes in the 28 patients studied so far, but reported improvements in two secondary end points of the trial.
Secondary end points included cerebral infarction, ischemic cerebrovascular disorder, and death from any cause.
Secondary end points in the CABANA trial include AF recurrence, stroke, quality of life, and cost effectiveness.
All claims that chlorthalidone was better than the other two rested solely on secondary end points, he said.
The median time to the first exacerbation and to the first exacerbation resulting in hospitalization, secondary end points, were also reduced among those on Spiriva, compared with those on placebo.
Secondary end points included episode duration to loss of hard crust, lesion healing time to normal skin, maximum lesion area, and cumulative lesion area.
Some of the study's secondary end points, including rates of severe exacerbations after treatment; days lost from work, school, or other daily activities due to asthma symptoms; and emergency department visits for respiratory symptoms, were lower among those treated with the device.
Secondary end points included changes in histologic features, liver enzymes, insulin resistance, anthropometric measures, and quality of life, Dr.